· Last reviewed: May 2026

When Should You Get a Mammogram — and How Often?

Mammogram guidelines changed in 2024. The US now recommends starting at 40; the UK starts at 50. Here's what each country's guidance says, why they differ, and how to know what applies to you.

Woman reviewing a health screening schedule, representing mammogram frequency guidance by age

Key Takeaway

In the US, current guidelines recommend mammograms every two years starting at age 40. In the UK, Canada, and Australia, national programmes typically begin inviting women at 50. The difference reflects a genuine scientific debate about weighing early detection against false positive rates — not a simple right-or-wrong answer.

Breast cancer is the most commonly diagnosed cancer in women worldwide. Most women who get a mammogram have no symptoms — they’re there because a guideline says it’s time. But knowing when that is, and how often it repeats, turns out to be more complicated than it looks.

For decades, public health bodies disagreed about when routine screening should begin. In 2024, the debate shifted: the US Preventive Services Task Force lowered its recommended starting age from 50 to 40. Most other countries didn’t follow. That divergence is worth understanding — not because one country is right and the others are wrong, but because the reasoning reveals how these decisions actually get made.

What mammography does

A mammogram is an X-ray of breast tissue. Screening mammography — as opposed to diagnostic mammography after symptoms appear — is done in people who feel well. The goal is to find changes that might indicate early-stage cancer before a lump can be felt.

The principle is straightforward: catching cancer earlier generally means less extensive treatment and better outcomes. But “generally” is doing a lot of work here. Not every cancer that appears on a mammogram would have caused symptoms or shortened a life. Detecting and treating those cases is overdiagnosis — real treatment with real side effects, for a disease that would never have become a problem. This is the core tension in the international debate about when to start.

Who needs a mammogram and when

For most women, mammography guidelines rest on two factors: age and individual risk.

Average risk means no personal history of breast cancer, no known high-risk gene variants (BRCA1/BRCA2), and no significant family history. Most women are in this category, and the country-specific guidelines below apply to them.

Higher risk includes women with a first-degree relative who had breast cancer before 50, known gene variants linked to higher risk, or prior chest radiation for other conditions. In these cases, earlier or more frequent screening — sometimes including MRI alongside mammography — is often recommended. That’s a conversation with a clinician, not a general guideline.

If you’re unsure which category you’re in, the adults’ health screening guide covers how to think about personal risk across different screening types.

What guidelines say by country

Country / RegionRecommended start ageFrequencyAuthority
United States40Every 2 yearsUSPSTF (2024)
United Kingdom50Every 3 yearsNHS Breast Screening Programme
Canada50Every 2–3 yearsCTFPHC (2018)
Australia50 (invited); 40–49 can self-referEvery 2 yearsBreastScreen Australia
Europe (most programmes)50Every 2 yearsEU Council / national bodies

Guidelines vary by country — check with your local health authority.

Why the US and UK disagree by a decade

The 10-year gap in starting age between the US and most other countries isn’t a disagreement about whether mammograms work. It’s a difference in how benefits and harms are weighed across a population.

Updated evidence on younger women. The USPSTF 2024 update incorporated new modelling showing that starting at 40 prevents more breast cancer deaths than starting at 50. The evidence was especially notable for Black women, who face higher rates of aggressive breast cancer in their 40s and have historically been underserved by a starting-age-of-50 approach. The UK and Canadian bodies reviewed similar data and reached a different conclusion about population-level benefit at 40–49.

False positive rates are higher at younger ages. Breast tissue is typically denser in women under 50, making mammograms harder to read and more likely to produce inconclusive results that require follow-up. A false positive means callbacks, additional imaging, sometimes a biopsy — and weeks of uncertainty. Regulators weigh this harm differently: the US system accepts a higher false positive burden in exchange for the mortality benefit of earlier detection; the NHS and Canadian guidelines prioritise reducing unnecessary procedures.

Different cost-effectiveness thresholds. Screening an entire population from 40 rather than 50 is expensive in aggregate. The US healthcare system generally accepts higher per-person costs to prevent a death than the NHS or Canadian provincial programmes. This isn’t a values judgment — it reflects structural differences in how healthcare is funded and organised.

Time lag in guideline reviews. Most bodies review evidence every five to ten years. Canada’s current breast cancer guideline dates from 2018. An update is in progress, and the outcome may narrow some of the international gap.

If you’re in your 40s and unsure

This is where guidance is most unsettled, and where a conversation with your doctor matters most.

In the US: if you’re 40 or older and average-risk, current guidelines support starting biennial mammograms.

In the UK: the NHS programme doesn’t invite women until 50, but if you have family history or personal risk factors, a GP referral for earlier screening is possible.

In Canada: the national programme begins at 50, but women in their 40s can discuss the decision with their doctor, particularly if there’s a family history.

In Australia: BreastScreen invites women 50–74, but women aged 40–49 are eligible to self-refer and attend a BreastScreen clinic without a GP referral.

Knowing your family history, understanding your risk, and having that conversation — ideally before the relevant age — is the most useful thing any woman can do. The FAQ section has more on how to approach preventive screening conversations with your care team.

Frequently Asked Questions

Staying on top of when your last mammogram was — and when the next is due — is the kind of detail that’s easy to lose track of, especially when guidelines change. Screening Clearing is a free iOS and Android app for tracking your personal health screening schedule. Enter what you’ve had done, and it keeps a clear record without storing your data anywhere outside your phone.

Start tracking your health checks today

Free for iOS and Android. Your data stays on your phone.

Always consult your doctor for personal medical decisions.

Screening Clearing Editorial

Articles are written for educational purposes and reviewed against current NHS, CDC, and USPSTF guidelines. This content does not constitute medical advice. Always consult your doctor for personal medical decisions.

Sources

  1. USPSTF. Breast Cancer Screening Recommendation (2024). 2024.
  2. NHS. Breast Screening (Mammogram). 2023.
  3. CTFPHC. Breast Cancer Screening Guidelines (2018). 2018.
  4. Australian Government Department of Health and Aged Care. BreastScreen Australia Programme. 2024.
  5. CDC. Mammograms. 2024.
  6. European Commission. Cancer Screening Initiative. 2022.

Start tracking your health checks today

Free for iOS and Android. Your data stays on your phone.

Always consult your doctor for personal medical decisions.